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Abstract
To study the receptor specificity of modern human influenza H1N1 and H3N2 viruses, the analogs of natural receptors, namely
sialyloligosaccharides conjugated with high molecular weight (about 1500 kDa) polyacrylamide as biotinylated and label-free probes, have
been used. Viruses isolated from clinical specimens were grown in African green monkey kidney (Vero) or Madin–Darby canine kidney
(MDCK) cells and chicken embryonated eggs. All Vero-derived viruses had hemagglutinin (HA) sequences indistinguishable from original
viruses present in clinical samples, but HAs of three of seven tested MDCK-derived isolates had one or two amino acid substitutions. Despite
these host-dependent mutations and differences in the structure of HA molecules of individual strains, all studied Vero- and MDCK-isolated
viruses bound to Neu5Ac 2-6Gal1-4GlcNAc (6SLN) essentially stronger than to Neu5Ac2–6Gal1–4Glc (6SL). Such receptor-
binding specificity has been typical for earlier isolated H1N1 human influenza viruses, but there is a new property of H3N2 viruses that has
been circulating in the human population during recent years. Propagation of human viruses in chicken embryonated eggs resulted in a
selection of variants with amino acid substitutions near the HA receptor-binding site, namely Gln226Arg or Asp225Gly for H1N1 viruses
and Leu194Ile and Arg220Ser for H3N2 viruses. These HA mutations disturb the observed strict 6SLN specificity of recent human
influenza viruses.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Influenza virus infection is initiated by interactions between
viral hemagglutinin and sialic acid containing cell receptors.
One of the main characteristics of receptor-binding specificity
of influenza viruses is the ability to discriminate between
Neu5Ac2–3Gal1 and Neu5Ac2–6Gal disaccharide motifs.
Depending on the nature of virus and the origin of cells
used for the isolation of influenza A and B viruses, there
have been various receptor-binding mutants obtained (Rob-
ertson, 1999). Isolation and propagation of human influenza
viruses in chicken embryonated eggs (CE) or in BHK-21
cells results in the selection of variants containing amino
acid substitutions in the vicinity of the hemagglutinint HA
receptor-binding site. As a rule, influenza viruses produced
* Corresponding author. Fax: 095-330-55-92.
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1 Abbreviations: Neu5Ac, N-acetylneuraminic acid; 3SL, Neu5Ac2–3-
Gal1–4Glc, 3-sialyllactose; 6SL, Neu5Ac2–6Gal1–4Glc, 6-sialyl-
lactose; 6SLN, Neu5Ac2–6Gal1–4GlcNAc, 6-sialyl-(N-acetyllac-
tosamine); PAA, polyacrylamide; biot, biotin; Sug-PAA-biot, biotinylated
polyacrylamide glycoconjugates; RBS, receptor-binding site; TN buffer,
0.02 M Tris–HCl, 0.15 M NaCl, pH 7.3; PBS, 0.02 M Na-phosphate, 0.15
M Nacl, pH 7.3.
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in CE display the ability to bind Neu5Ac 2–3 linked to Gal
residue, i.e., Neu5Ac2–3Gal-containing receptors, which
is more typical for avian species (Katz et al., 1987; Ito et al.,
1997; Govorkova et al., 1999b). In contrast, human viruses
isolated and propagated solely in mammalian cell lines such
as Madin–Darby Canine Kidney (MDCK), Vero, LLC-
MK2, and MRC-5 bind to Neu5Ac2–6Gal-containing re-
ceptors (Katz et al., 1990; Govorkova et al., 1995, 1999a;
Schepetiuk and Kok, 1993). Actually, the disaccharide-
receptor approximation cannot explain all of the collected
data. As was shown earlier (Gambaryan et al., 1995, 1997),
human H1N1 strains bound to Neu5Ac2–6Gal1–4Glc-
NAc trisaccharide better than to Neu5Ac2–6Gal1–4Glc,
while human H3N2 viruses had no ability to distinguish
between these two structures.
After 1992, human influenza H3N2 viruses isolated in
Vero and MDCK cells acquired new properties; namely,
they were unable to grow in CE and agglutinate chicken red
blood cells (CRBCs) (Grassauer et al., 1998; Nobusawa et
al., 2000; Medeiros et al., 2001). The key amino acid resi-
dues of the receptor-binding site, responsible for these new
properties of modern isolates, have been identified (Nobu-
sawa et al., 2000; Medeiros et al., 2001). However, fine
receptor-binding specificity of recent human viruses was not
determined as of yet.
In the present study we have investigated receptor-bind-
ing properties of modern human H3N2 and H1N1 influenza
viruses isolated from the same clinical specimen in Vero,
MDCK cells, and CE. We have demonstrated that all Vero-
and MDCK-derived viruses prefer 6SLN trisaccharide to
other sialyloligosaccharides. Such specificity has been typ-
ical for previous H1N1 human viruses (Gambaryan et al.,
1997, 1999), but it is a new property of recent H3N2
isolates.
Results
We have studied the receptor-binding properties of a set
of recent human influenza A viruses, isolated in Vero and
MDCK cells and in chicken embryos (V-, M-, and E-vari-
ants, respectively). Some properties of these virus isolates,
namely the ability to grow in CE and agglutinate CRBC, as
well as glycosylation, were investigated and described ear-
lier (Romanova et al., 2003).
Affinity of V-, M-, and E-variants of influenza viruses
toward biotinylated polyvalent synthetic
sialoglycoconjugates
In contrast to isolates of the previous years, the viruses of
both H1N1 and H3N2 subtypes used in our study (isolated
in different host systems) displayed low or no binding
activity in a fetuin-binding inhibition assay (Gambaryan et
al., 1999). Therefore, another approach described by Ma-
trosovich et al. (2000) was chosen to investigate the fine
receptor-binding specificity of recent human influenza virus
isolates. Namely, purified viruses were directly coated onto
the plates, and their receptor-binding activities were mea-
sured using a set of Sug-PAA-biot conjugates (3SL-,
6SL-, and 6SLN-PAA-biot) followed by streptavidin–per-
oxidase staining (Tables 1 and 2).
The H1N1 (A/HK/1134/98 and A/HK/1035/98) V- and
M-variants exhibited the highest affinity for 6SLN (Kd
108 M), but a lower one for 6SL (only A/HK/1134/98
M-variant displayed high affinity for 6SL) and a substan-
tially lower affinity for 3SL. The H1N1 E-derived variants
displayed a different ability to bind 6SL-PAA-biot and
6SLN-PAA-biot, whereas their affinity for 3SL was dra-
matically increased. A/HK/1134/98E variant was able to
bind only to the 3SL-trisaccharide with a high affinity (Kd
108 M), whereas the A/HK/1035/98E virus demonstrated
high binding with all synthetic receptor analogs.
All studied H3N2 Vero and MDCK variants displayed a
high receptor-binding affinity for the 6SLN-receptor (Kd
107 M) and a lower binding to 6SL. This strict receptor-
binding specificity of these strains to 6SLN distinguished
them from the MDCK -isolates of earlier H3N2 virus strains
(Gambaryan et al., 1997). As seen from Table 2, human
influenza H3N2 virus A/NIB/26/90M, isolated in 1990,
bound to both 6SL and 6SLN with the same high affinity.
When the H3N2 virus A/HK/1180/99V was passaged twice
in CE with a high (105 PFU/egg) multiplicity of infection,
the E-variant (designated as A/HK/1180/99 2V2E), bearing
Table 1
Receptor-binding activity of H1N1 variants of modern human influenza viruses
Isolates Passage historya Substitutions in HA1
comparing to swab virus
Kd (M of Neu5Ac)b
6SLN-PAA-biot 6SL-PAA-biot 3SL-PAA-biot
A/HK/1035/98 3Vero 0.01 2.0 4.0
2MDCK 0.02 1.0 10
2CE Asp225Gly 0.02 0.02 0.02
A/HK/1134/98 2Vero 0.06 0.3 3.0
2MDCK 0.03 0.05 0.5
2CE Gln226Arg 10 10 0.02
a Passage history with the number of passages in Vero, MDCK, or chicken eggs (CE).
b Kd was determined as described under Materials and methods.
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two substitutions in HA1 at positions 194 (Leu 3 Ile) and
220 (Arg 3 Ser), was obtained. To exclude the effect of
host-specific glycosylation on receptor-binding properties,
the A/HK/1180/99 2V2E-isolate was passaged once in Vero
cells before its comparison with the initial Vero-grown
parent virus. Receptor-binding specificity of A/HK/1180/99
2V2E1V-variant became similar to earlier isolates of H3N2
human viruses recognizing 6SL-, as well as 6SLN-trisac-
charides. None of the H3N2 viruses under investigation
were able to bind to 3SL-PAA-biot.
Table 3
Inhibition of virus-induced reaction of HBRC agglutination by polyvalent sialosides
Isolates Substitutions in HA1
comparing to swab virus
Concentration of inhibitor,a M of Neu5Ac
6SLN-PAA 6SL-PAA 3SL-PAA
H3N2 A/NIB/26/90
5MDCK 0.004 0.002 20.0
A/HK/1180/99
3Vero 0.05 5.0 40.0
2MDCK 0.01 5.0 40.0
2Vero2CE1Vero Leu194lle
Arg220Ser
0.03 0.05 20.0
A/HK/1182/99
3Vero 0.05 5.0 40.0
3MDCK 0.05 5.0 40.0
A/Sw/7729/98
3Vero 0.02 5.0 40.0
3MDCK Glu129Gly
Arg229Lys
0.02 1.0 40.0
A/HK/1143/99
3Vero 0.03 5.0 40.0
2MDCK Asn133Asp
Gly218Glu
0.05 5.0 40.0
A/HK/1144/99
2Vero 0.06 5.0 20.0
3MDCK Arg220Gly 0.05 5.0 20.0
H1N1 A/HK/1035/98
3Vero 0.05 5.0 40.0
2CE Asp225Gly 0.06 0.1 0.04
A/HK/1134/98
2Vero 0.007 5.0 40.0
2CE Gln226Arg 5.0 5.0 0.15
a Minimal concentration at which inhibition was still observed.
Table 2
Receptor-binding activity of H3N2 variants of modern human influenza viruses
Isolates Passage historya Substitutions in HA1
comparing to swab virus
Kd (M of Neu5Ac)b
6SLN-PAA-biot 6SL-PAA-biot 3SL-PAA-biot
A/NIB/26/90 5MDCK 0.04 0.02 20
A/HK/1180/99 3Vero 0.25 2.0 20
2MDCK 0.3 8.0 20
2Vero2CE1Vero Leu194lle
Arg220Ser
0.5 0.2 20
A/HK/1182/99 3Vero 0.12 1.0 20
3MDCK 0.12 4.0 20
A/Sw/7729/98 3Vero 0.5 8.0 20
3MDCK Glu129Gly
Arg229Lys
0.2 2.0 20
A/HK/1143/99 3Vero 0.25 4.0 20
2MDCK Asn133Asp
Gly218Glu
0.3 8.0 20
A/HK/1144/99 2Vero 0.12 2.0 20
3MDCK Arg220Gly 0.12 2.0 20
a,b See the footnotes to Table 1.
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Receptor-binding activities of influenza viruses in a
hemagglutination inhibition assay
The hemagglutination inhibition assay (Mammen et al.,
1995; Choi et al., 1996) was performed using a set of
sialyloligosaccharides, coupled with a high molecular
weight polyacrylamide without a label. The minimal con-
centrations of sialosides, at which inhibition of HRBC ag-
glutination was observed, are shown in Table 3.
The hemagglutination activity of both H1N1 and H3N2
(MDCK and Vero) isolates was effectively inhibited by
6SLN-PAA (108 M). Only the A/Sw/7729/98M virus,
having two amino acid substitutions, Glu129Gly and
Arg229Lys, near RBS in HA1 compared to V-variant was
inhibited by 6SL-PAA at an elevated concentration (106
M). The H3N2 virus A/NIB/26/90M, isolated in 1990, as
well as A/HK/1180/99 2V2E1V-variant, bearing mutated
HA1, was inhibited by both 6SL-PAA and 6SLN-PAA.
All other studied H3N2 viruses were not inhibited by either
6SL-PAA or 3SL-PAA. Thus, the strict affinity of recent
human H3N2 influenza viruses for 6SLN, but not 6SL, has
been confirmed by two different methods. Agglutination
induced by both E-variants of H1N1 viruses was inhibited
in general by 3SL-PAA; however, one of the strains,
namely A/HK/1035/98E, was also inhibited by 6SL-PAA
and 6SLN-PAA.
It is noteworthy that the use of virus-containing cultural
fluids instead of purified virus samples demonstrated the
same results in this assay.
Discussion
Data on the receptor-binding specificity of modern influ-
enza viruses are the starting point for the designing of
antiinfluenza virus drugs and live influenza vaccines and are
of great importance for understanding the mechanisms of
virus evolution and interspecies transfer. In this study we
investigated a receptor specificity of H1N1 and H3N2 in-
fluenza virus strains that are currently circulating in the
human population. Special attention was paid to the inves-
tigation of the receptor specificity of modern H3N2 viruses,
new biological properties of which were documented re-
cently (Grassauer et al., 1998; Nobusawa et al., 2000; Me-
deiros et al., 2001). To mimic the natural process of poly-
valent cooperative interactions between the human
influenza virus and multiple copies of virus receptor on the
surface of the host cell, we studied binding of the virus
isolates after a limited number of passages in the mamma-
lian cell cultures with sialyloligosaccharides, coupled to a
high molecular weight polyacrylamide.
Both V- and M-variants of the H1N1 viruses displayed
the highest affinity for 6SLN, a lower one for 6SL and the
lowest for 3SL. These results are in full accordance with
earlier observations, when preferential binding of human
H1N1 viruses to a 6SLN-receptor was shown (Gambaryan
et al., 1997, 1999; Matrosovich et al., 1997).
At the same time, E-variants of viruses A/HK/1035/98
and A/HK/1134/98 had crucial single-point mutations in the
HA receptor-binding site (Asp225Gly and Gln226Arg, re-
Fig. 1. Three-dimensional model of the X-31 HA complexed (Eisen et al., 1997) with LSTc pentasaccharide (DS ViewerPro 5.0, Accelrys Inc. software).
The glycosylated amino acids (blue) and amino acid substitutions appeared in HA of CE isolated human viruses (green) are shown on two neighboring HA1
subunits (colored by pale purple and mint green).
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spectively, Fig. 1), these replacements led to a dramatic
increase in affinity for 3SL.
The Asp225Gly change can be called a “reverted muta-
tion” because Gly225 is the constant amino acid of avian
influenza viruses, which have been known to recognize the
3SL-receptor. It has been shown (Sauter et al., 1992) that
carbonyl oxygen of Gly225 forms a hydrogen bond with the
6-OH group of galactose residue of 3SL. Thus, it is not
surprising that such an amino acid substitution increases
affinity of the A/HK/1035/98E virus for 3SL. In addition,
positive charge shift (Gly instead of Asp) can also favor HA
binding with other sialosides that is confirmed by the in-
creasing affinity of the virus for 6SL.
The Gln226Arg mutation in HA of the H1 subtype (A/
HK/1134/98E) is interesting from the point of view that a
226 amino acid is the key one in Neu5Ac2–3Gal vs
Neu5Ac2–6Gal recognition by H2, H3, and as it has been
shown recently, H9 virus subtypes (Connor et al., 1994;
Matrosovich et al., 2000, 2001). For the H2, H3, and H9
subtypes the presence of Gln at the 226 position of HA
correlates with the binding of neuraminic acid 2–3 linked to
galactose residue, whereas HA with Leu226 recognizes 2–6
sialyloligosaccharides. It is significant that although there is
Gln at position 226 of human H1N1 viruses, these viruses
preferentially bind to 6SLN. Thus, human H1N1 viruses
have acquired an alternative mechanism of 6SLN receptor
recognition: while retaining Gln at the 226 position, substi-
tutions of other amino acids, normally constant for avian
viruses, at positions 225, 190, 194, and 138, have taken
place (Gambaryan et al., 1999; Matrosovich et al., 1997).
The appearance of Arg instead of Gln at position 226 of H1
HA, resulting from the cultivation of the human virus isolate
in chicken embryos, has been detected for the first time.
This finding expands the frameworks of the previously
observed cause–effect mechanism “substitution at the 226
position-receptor specificity.” Whereas for H2, H3, and H9
HA the replacement of Gln226 for more hydrophobic Leu
favors the recognition of Neu5Ac2–6Gal-containing oli-
gosaccharides, in the case of H1 HA the emergence of more
polar and bulky Arg instead of Gln at this position leads to
dramatic increasing virus affinity for 3SL.
During the last decade, several substitutions have ap-
peared in the HA of human H3N2 viruses at the amino acid
positions which had previously been considered to be con-
served for human isolates and responsible for the
Neu5Ac2–6Gal receptor-binding properties of these vi-
ruses. Thus, Ile and then Val became the predominant res-
idue at position 226 of H3 HA instead of Leu, which was
typical for HA of earlier H3N2 human isolates (Fitch et al.,
1997; Bush et al., 1999; Medeiros et al., 2001). In more
recent strains, the Glu190Asp substitution has been detected
(Nobusawa et al., 2000). Besides, other mutations leading to
an increase of the number of HA potential glycosylation
sites have occurred. Their number reached 11 in the latest
H3N2 virus isolates (Hay et al., 2001).
Evidently these changes, which have been occurring in
the HA primary structure of H3N2 viruses during the last
decade, have stipulated new properties of modern isolates.
For example, recent H3N2 viruses have lost the ability to
grow in chicken embryos and agglutinate avian erythro-
cytes. According to Nobusava et al. (2000), the only sub-
stitution, Asp instead of Glu at position 190, causes the
H3N2 virus an inability to agglutinate chicken erythrocytes.
Other data (Medeiros et al., 2001) suggest that the alteration
of virus agglutinating pattern is rather related to the amino
acid changes at position 226, namely the virus ability to
bind CRBC decreases gradually in the following evolution
row for H3 HA: Gln2263 Leu3 Ile3 Val. The authors
have also demonstrated that amino acid residues at positions
193 and 194 can affect virus binding with various erythro-
cyte species.
An increasing number of HA glycosylation sites can also
greatly influence the virus binding with receptors. Fig. 1
shows the arrangement of glycosylation sites on the top part
of the HA subunit of modern H3N2 viruses. Carbohydrate
chains at Asn133 of the one HA1 subunit, Asn165 and Asn
246 of another subunit, surround red blood cells (RBS) and
thus can cause spatial hindrance during the receptor binding.
The length and nature of the carbohydrate chains could
affect the binding of HA with receptors. Despite the iden-
tical receptor-binding characteristics of V- and M-variants
of the same H3N2 virus toward multivalent synthetic recep-
tor analogs, they differ in the ability to agglutinate CRBC.
While all MDCK-isolated viruses induce the agglutination
of CRBC, their Vero counterparts are unable to do so [the
data on hemagglutination of chicken and human erythro-
cytes are present in our previous article (Romanova et al.,
2003)]. As we have shown, cell-specific glycosylation of
HA provided by MDCK and Vero cells causes distinct
hemagglutinating properties of H3N2 V- and M-isolates.
Until recently, determination of the fine receptor-binding
specificity of modern H3N2 viruses has been difficult.
These viruses poorly bound both fetuin and previously used
synthetic receptor analogs with an average degree of poly-
merization n  300 (Fig. 2). The usage of synthetic oligo-
Fig. 2. Structural formulas of biotin-labeled polyacrylamides, Sug-PAA-biot,
with pendant sialyloligosaccharides. The polymers were synthesized by cou-
pling of -amino glycosides and biotin with poly(N-oxysuccinimide acrylate)
and contained 20 moiety of Sug and 5 moiety of biotin per 100 monomer units
of the polymer carrier. The average degree of polymerization (n) of the PAA
carrier was estimated by gel permeation chromatography.
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saccharides coupled to high molecular weight polyacryl-
amide (n  13,000), i.e., more polyvalent than ones used
earlier, allowed for the overcoming of this obstacle. We
have studied receptor-binding properties of recent A/Syd-
ney/5/97-like viruses, bearing Asp 190, Val 226, and
Leu194 at key positions and 10–11 potential glycosylation
sites on HA. Despite the considerable differences in H3 HA
amino acid sequences (e.g., HA1 of viruses A/HK/1180/99
and A/Sw/7729/98 differed by many positions near RBS),
all studied M and V H3N2 isolates possessed similar recep-
tor-binding properties. They displayed the highest affinity
for 6SLN, whereas the binding to 6SL was one order of
magnitude weaker. In the inhibition assay only 6SLN-PAA
demonstrated inhibition of the interaction of these viruses
with human red blood cells (HRBC).
It should be noted that H3N2 viruses circulating earlier
in the human population did not distinguish between 6SLN
and 6SL (Matrosovich et al., 1997; Gambaryan et al., 1997,
1999). Receptor-binding activity of A/NIB/26/90 virus, one
of the typical strains isolated in the 90th, which was de-
tected in the assay system used for the investigation of
modern viruses, was identical for both 6SLN and 6SL
(Tables 2 and 3). This result has a high correlation with the
data reported earlier (Gambaryan et al., 1997). It is inter-
esting that the only available H3N2 mutant, A/HK/1180/99
2V2E1V, bearing two amino acid substitutions in HA1
(Ile194 instead of Leu and Ser220 instead of Arg, Fig. 1),
acquires the ability to equally bind 6SL and 6SLN (Tables
2 and 3). In contrast to earlier human H3N2 influenza virus
isolates, which displayed the ability to bind 3SL after
adaptation to CE (Gambaryan et al., 1997), the A/HK/
1180/99 2V2EIV isolate has no such affinity.
To elucidate which of the two amino acid substitutions
Leu194Ile or Arg220Ser affects the changing of receptor
activity of the mutant variant of H3N2 virus, we have
compared the binding properties of influenza virus A/HK/
1144/99 V- and M-variants differing in only one Arg220Gly
position in HA1. The receptor-binding specificity of A/HK/
1144/99 M-isolate, having Gly220, has the same pattern of
binding as the corresponding Vero-variant and all other
H3N2 isolates, bearing Arg220. Thus, another mutation,
Leu194Ile, of A/HK/1180/99 2V2E1V virus obviously is
involved in the recognition of 6SL trisaccharide. Taking
this into account, we suppose that the Leu194Ile replace-
ment disturbs the architecture of wild-type H3 HA, the
receptor-binding site of which is focused on the recognition
of 6SLN. It was shown earlier (Sauter et al., 1989; Eisen et
al., 1997) that Leu 194 formed van der Waals contact with
Neu5Ac residue of 6SLN and that amino acid change at
this position influenced the hemagglutinating properties of
the mutant virus (Martin et al., 1998). Medeiros et al. (2001)
demonstrated that the Leu194Ile change conferred the abil-
ity of recent H3N2 human strains to agglutinate sheep
erythrocytes. The idea that 6SLN rather than 6SL is a true
human influenza virus receptor has been proposed by Eisen
et al. (1997). According to this work, the Neu5Ac2–6-
Gal1–4GlcNAc trisaccharide fragment of LSTc pen-
tasaccharide(Neu5Ac2–6Gal1–4GlcNAc1–3Gal1–4-
Glc), being in a complex with the HA of X-31 virus
(H3N2), has a folded conformation that is stabilized by a
hydrogen bond and van der Waals contacts between
Neu5Ac and GlcNAc moieties. This folded conformation of
6SLN suits the architecture of the hemagglutinin receptor-
binding site much better than the extended conformation of
6SL trisaccharide. Our results on receptor-binding speci-
ficity of human influenza viruses H3N2 correlate well with
this hypothesis. We have proven experimentally that mod-
ern human influenza viruses of H3N2 subtype acquired a
well-defined ability to distinguish between 6SLN and 6SL
structures. What advantages does this new property provide
to modern viruses, what is the molecular mechanism of this
acquisition, and is this mechanism connected to the reduced
affinity of modern strains toward cell receptors? We will
address these questions in further research.
Materials and methods
Materials
For receptor-binding assays, 96-well PV-microtiter
plates from Costar, USA, and horseradish peroxidase–
streptavidin conjugate and o-phenylenediamine from
Boehringer Mannheim, Germany, were used. The synthesis
of low molecular weight (30 kDa) glycoconjugates Sug-
PAA and Sug-PAA-biot was described earlier (Bovin et al.,
1993; Tuzikov et al., 2000), and the synthesis of high
molecular weight (about 1500 kDa) glycoconjugates (Fig.
2) will be published. According to monosaccharide analysis
data, the molar content of Sug in all conjugates is 20%, and
the molar content of biotin in Sug-PAA-biot is 5%.
Cells
Vero (WHO-certified) and MDCK cell lines were ob-
tained from the American Type Culture Collection (ATCC).
Vero cells were adapted and further cultivated in DMEM/
Ham’s F12 (Biochrom) protein-free medium (Kistner et al.,
1999). MDCK cells were cultivated in DMEM/Ham’s F12
(1:1) medium supplemented with 2% of heat-inactivated
fetal calf serum (Gibco).
Influenza strains
Clinical specimens from influenza patients were obtained
from the Central Laboratory, Geneva, Switzerland (Sw),
seasons 1996/97 and 1997/98; and Virus Unit, Queen Mary
Hospital, Hong Kong (HK), seasons 1997/98 and 1998/99.
Virus A/NIB/26/90 was obtained from the influenza virus
repository of National Institute for Biological Standards and
Control (NIBSC, Potters Bar, UK) and propagated in
MDCK cells.
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Vero, MDCK cells, and CE (amniotic cavity of 10-day-
old eggs) were infected with a combination of throat and
nose swabs. Viruses of a second passage were used for
sequencing. Viruses of swab specimens were sequenced
directly from clinical material without any additional pas-
sages.
Propagation and titration of viruses
Viruses were propagated in Vero or MDCK cells in
DMEM/Ham’s F12 medium containing 5 g/ml of trypsin
(Sigma, T4549) at 33°C. Hemagglutination assay was per-
formed with 0.5% suspension of CRBC or HRBC (group O,
Rh) at 4°C. The infectious titer of viruses was deter-
mined in Vero cells by plaque assay in the medium con-
taining DMEM/Ham’s F12.4 mM L-glutamine, 5 g/ml of
trypsin, 0.01% of DEAE-dextran (Pharmacia), and 0.6% of
agar (Sigma) and expressed in plaque forming units. Eval-
uation of virus growth in CE was done by the infection of
10-day-old embryonated eggs with inoculum containing
104–105 PFU/egg of a virus (Romanova et al., 2003).
Virus purification
Virus containing cultural fluid was incubated with 0.5 M
NaCl for 30 min at room temperature followed by low-
speed centrifugation. The supernatant was layered on top of
30% sucrose prepared in TN buffer and centrifuged at
24,000 rpm for 1.5 h at 4°C (Beckman L-50, SW-27 rotor).
The pellet of virus was resuspended in PBS or TN buffer.
After this, virus suspension was clarified by low-speed cen-
trifugation and stored at 4°C in buffer, containing 0.01%
NaN3.
Solid-phase direct binding assay for measuring influenza
virus receptor-binding activity
Binding specificity of influenza viruses was investigated
in a direct binding assay. Plates were coated with a purified
influenza virus with the titer of 4–8 hemagglutination units
(50 l/well) at 4°C for 16 h followed by washing with TN
buffer. After that 100 l/well of blocking solution (TN
buffer containing 0.1% of gelatin) was added, and then
plates were kept at room temperature for 90 min and washed
with cold TN buffer containing 0.05% of Tween 20 (wash-
ing solution). After the addition of Sug-PAA-biot, 45 l/
well in the working buffer [TN buffer with 0.01% of Tween
20; 0.01% of gelatin, and 3 M of the neuraminidase
inhibitor (2,3-didehydro-2,4-dideoxy-4-amino-N-acetyl-D-
neuraminic acid)] plates were allowed to stay at 4°C for 2 h.
The starting concentration of Sug-PAA-biot was 20 M on
sialic acid; the following twofold serial dilutions were used.
Plates were washed with a cold washing solution and incu-
bated with streptavidin–peroxidase in the working buffer at
4°C for 1 h. After washing, 50 l/well of substrate solution
(0.1 M sodium acetate, pH 5.0, containing 4 mM o-phen-
ylenediamine and 0.004% H2O2) was added and the reac-
tion was stopped with 2 M H2SO4. Optical density was
determined at 492 nm with a Multiscan plate reader (Lab-
systems, Finland). The Kd was determined as Neu5Ac con-
centration at the point Amax/2 of Scatchard plots. The re-
ported values of Kds represent an average of at least four
independent experiments, performed on different days.
Twofold or higher differences in the values of Kds presented
in the tables are statistically significant.
Hemagglutination inhibition assay for the measuring of
influenza virus receptor-binding activity
To the subsequent twofold dilutions of Sug-PAA-biot
(20 l/well) in PBS, containing 3 M of neuraminidase
inhibitor, 4 hemagglutination units of purified virus in PBS
(20 l/well) were added. After incubation at room temper-
ature for 10 min, the 0.5% suspension of HRBC (40 l/
well) in PBS was added. The plates were allowed to stay at
4°C for 30–60 min, and the minimal concentration of Sug-
PAA-biot (as M of Neu5Ac) required for complete inhi-
bition of hemagglutination was determined. The reported
values of minimal concentrations of inhibitors represent an
average of at least four independent experiments, performed
on different days. The absolute values of minimal concen-
trations varied in different experiments, but the relative
concentrations of inhibitors were highly reproducible, per-
mitting the use of averaged data for this variable.
Gene amplification
Viral RNA was extracted from tissue culture supernatant,
allantoic fluid, or swab material using Ultraspec reagent (Bio-
tecx). C-DNAs were synthesized using the M-MuLV reverse
transcriptase (MBI). Three overlapping parts of the HA gene
were amplified by PCR using specific primers (sequence avail-
able upon request). The PCR products were purified using Gel
Band Purification Kit (Amersham Pharmacia Biotech) and
sequenced (SEQLAB GmbH, Germany). The sequences were
analyzed using Lasergene 99 software. The H3 numbering
system was used throughout the study of influenza A viruses.
The GenBank Accession Nos. for the sequenced viruses are
as follows: AF386776, AF386781, AY032978, AY035588,
AY035589, AY035591, and AY035592.
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